Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Jukema

Showing results (161-170 of 225) with videos related to

Pageof 23
Sort By:
Circulation|October 4, 2000
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study GroupJ J Kastelein, J W Jukema, A H Zwinderman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2001
Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in miceS W van De Poll, T J Römer, O L Volger, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 15, 2016
Treatment variation in stent choice in patients with stable or unstable coronary artery diseaseL T Burgers, E A McClellan, I E Hoefer, et al.
The International Journal of Cardiovascular Imaging|May 27, 2011
Performance and efficacy of 320-row computed tomography coronary angiography in patients presenting with acute chest pain: results from a clinical registryJ E van Velzen, F R de Graaf, L J Kroft, et al.
Research and Practice in Thrombosis and Haemostasis|July 2, 2024
Performance of risk scores in predicting major bleeding in left ventricular assist device recipients: a comparative external validationS F B van der Horst, Y de Jong, N van Rein, et al.
Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.
The American Journal of Cardiology|April 6, 1999
Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosisM P de Maat, J W Jukema, S Ye, et al.
The Pharmacogenomics Journal|May 2, 2012
Added value of pharmacogenetic testing in predicting statin response: results from the REGRESS trialF H van der Baan, M J Knol, A H Maitland-van der Zee, et al.
Research and Practice in Thrombosis and Haemostasis|September 16, 2024
Erratum to 'Performance of Risk Scores in Predicting Major Bleeding in Left Ventricular Assist Device (LVAD) Recipients: a Comparative External Validation. '[Res Pract Thromb Haemost. 2024;8:e102437]S F B van der Horst, Y de Jong, N van Rein, et al.
Circulation|October 3, 2007
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptomsA O Kraaijeveld, S C A de Jager, W J de Jager, et al.
Pageof 23

Showing results (161-170 of 225) with videos related to

Sort By:
Pageof 23
Circulation|October 4, 2000
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study GroupJ J Kastelein, J W Jukema, A H Zwinderman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2001
Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in miceS W van De Poll, T J Römer, O L Volger, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 15, 2016
Treatment variation in stent choice in patients with stable or unstable coronary artery diseaseL T Burgers, E A McClellan, I E Hoefer, et al.
The International Journal of Cardiovascular Imaging|May 27, 2011
Performance and efficacy of 320-row computed tomography coronary angiography in patients presenting with acute chest pain: results from a clinical registryJ E van Velzen, F R de Graaf, L J Kroft, et al.
Research and Practice in Thrombosis and Haemostasis|July 2, 2024
Performance of risk scores in predicting major bleeding in left ventricular assist device recipients: a comparative external validationS F B van der Horst, Y de Jong, N van Rein, et al.
Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.
The American Journal of Cardiology|April 6, 1999
Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosisM P de Maat, J W Jukema, S Ye, et al.
The Pharmacogenomics Journal|May 2, 2012
Added value of pharmacogenetic testing in predicting statin response: results from the REGRESS trialF H van der Baan, M J Knol, A H Maitland-van der Zee, et al.
Research and Practice in Thrombosis and Haemostasis|September 16, 2024
Erratum to 'Performance of Risk Scores in Predicting Major Bleeding in Left Ventricular Assist Device (LVAD) Recipients: a Comparative External Validation. '[Res Pract Thromb Haemost. 2024;8:e102437]S F B van der Horst, Y de Jong, N van Rein, et al.
Circulation|October 3, 2007
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptomsA O Kraaijeveld, S C A de Jager, W J de Jager, et al.
Pageof 23